Clinical Research Site

Pittsburgh, Pennsylvania 15213-3403

0 studies enrolling now · 5 studies all time

What they study most

Hidradenitis Suppurativa, Pulmonary Aspergillosis, Refractory IPA, Uveitis

Studies at this site

• An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) — Completed
• Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) — Stopped early
• Hidradenitis Suppurativa Study of Izokibep — Stopped early
• Hidradenitis Suppurativa Phase 2b Study of Izokibep — Completed
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis — Stopped early